Adamax

ʻO Adamax

ʻO Adamax

ʻO Adamax kahi heptapeptide synthetic i loaʻa mai ka semax; ʻO ke kaʻina amino acid ponoʻī ʻo Ac-MEHFPG-AG-NH₂

Pane wikiwiki

ʻO Adamax kahi derivative synthetic optimized o Semax me ka lipophilicity hoʻonui a me ka paʻa enzymatic.. Hoʻokomo maikaʻi ʻo ia i ka pale koko-lolo, hoʻoponopono i ka ʻōlelo BDNF, hoʻonui i ka neuroplasticity, hoʻomaikaʻi i ka hoʻomanaʻo a me ka nānā ʻana, a pale i nā neurons mai ke kaumaha oxidative no ka noiʻi neurological.

SKU: 198802 Māhele:
Kaʻana like i kāu aloha

ʻO Adamax kahi synthetic heptapeptide loaa mai ʻaʻole lohe; ʻO ke kaʻina amino acid ponoʻī ʻo Ac-MEHFPG-AG-NH₂.

Semax pono'ī, he apana o ka hormone adrenocorticotropic (ACTH), Loaʻa iā ia nā waiwai neurotrophic a me ka cognitive-enhancing.

ʻO nā palena hoʻolālā i loko o ka semax e alakaʻi i nā palena koʻikoʻi i kona hapalua o ke ola a me ka maikaʻi o ka hele ʻana i ka pale koko-lolo..

No ka hoʻohaʻahaʻa i kēia mau palena, ua hoʻokomo nā ʻepekema i kahi hui adamantylacetate nui ma o hoʻopaʻa covalent ma ka pauku carboxyl.

Ua hoʻomaikaʻi nui kēia hoʻololi i ka pharmacokinetic waiwai o ka mole peptide.

ʻO ka hoʻokomo ʻana i kēia ʻāpana e hāʻawi kokoke i ke kūpaʻa piha i ka hope hoʻohaʻahaʻa enzymatic; ʻO ka manawa paʻa o ke ʻano hana o adamax i loko o ke kino ua lōʻihi loa.

ʻOi aku ka hoihoi, ka mea i olelo mua ia 'akamai’ Hoʻolālā ka hoʻolālā i ka hoʻonui ʻana i ka pono me ka peptide e ʻaʻa ai i ʻōlelo ʻia, a ua hoʻokō ʻia ka kikoʻī a me ka koho.

ʻAʻole hoʻopaʻapaʻa i ka hana biological, Ua mālama ʻia a hoʻonui ʻia paha nā hopena a pau o ka semax.

Kaʻina

Ac-MEHFPGP-Adam-NH2

Helu CAS

/

ʻĀpana Molekala

C50H68N10O12S

Kaumaha Molekala

1033.212

Imi No Adamax:

1.ʻO ka maikaʻi o ka lāʻau lapaʻau a me ka hiki ke hoʻomaʻamaʻa

Ua hōʻike ʻia nā hoʻokolohua lapaʻau iā Adamax e hoʻokō iā Semax i ka hoʻolaha ʻana i ka ulu a me ka pale o kumu neurotrophic i loaʻa i ka lolo (BDNF) a i kahi lae kumu ulu aʻalolo (NGF).

Ke hoʻololi nei iā Semax ma ke ʻano he therapeutic agent, no nā maʻi psychiatric a i ʻole ka hoʻonui ʻana i ka ʻike pili kanaka, he mea hiki loa.

2.Hoʻonui ʻike (ʻO ka naʻauao kahi ʻāpana)

ʻO ka hoʻoulu ʻana o ka BDNF upregulation ka hana nui a Adamax.

ʻO ka hana pūnaewele neuronal, ʻO ka hanauna neuron hou / ʻokoʻa a me nā hoʻomaikaʻi synaptic pili i ka mea e nānā ʻia nei ka noiʻi.

Hoʻonui pū ʻia ka hana hippocampal a me prefrontal cortex.

Loaʻa nā hui hoʻokolohua lōʻihi a e hoʻomau ʻia e hōʻike, me ka nui, ʻoi aku ka maikaʻi o ka hoʻomanaʻo a me ke aʻo ʻana.

3.Nā hopena neuroprotective

ʻO ka hoʻonui ʻana i ka naʻau a me ka hoʻonui ʻana i ka naʻauao ʻo Adamax ʻaʻole wale mai kāna hoʻolaha pololei ʻana i ka ulu ʻana o ka neural cell., akā, mai nā waiwai neuroprotective i hōʻike ʻia.

Ua hōʻike ʻia ka hōʻemi maikaʻi ʻana o nā wahi cerebral infarction i nā mea maʻi stroke; ʻO ka hoʻoulu ʻana a me ka hoʻihoʻi hou ʻana o nā cell necrotic like ʻole kekahi mea nui o kēia neuroprotection.

Hoemi ana hoʻomāʻewaʻewa a me ka hāʻawi ʻana i nā hopena antioxidant kokoke mau, nā hana i palapala maikaʻi ʻia.

Hoʻonoho iā ia iho i loko o kēia aupuni, Ua paʻa ʻo Adamax i ka ʻōlelo hoʻohiki ma ke ʻano he mea lapaʻau maoli no nā maʻi neurodegenerative – ʻO Alzheimer ke kumu hoʻohālike, Ke hahai nei ʻo Parkinson ma hope.

4.Hoʻomaha i ka pilikia a me ka hopohopo

Hoʻonui ʻo Adamax i ke kanaka hiki ke hoʻololi i nā loli kaiapuni; pono ka lolo pono'ī e hoʻololi koke, a pale aku, nā ʻano koʻikoʻi physiological i hopena mai kēia mau hoʻololi kaiapuni wikiwiki.

ʻO ka mālama ʻana i kekahi ʻano homeostasis ka hopena hope.

Modulation o ka hypothalamic-pituitary-adrenal (HPA) axis ke kikowaena o keia hana, hoʻonui a hoʻemi paha i ka hoʻokuʻu kūpono o nā neurotransmitters, nā pane hoʻoluhi liʻiliʻi a pau’ kaohi ana.

Anxiolytic ʻO nā hopena kahi pōmaikaʻi mua – ka hiamoe a me ka hemahema o ka noonoo (nā hopena ʻaoʻao āpau kokoke i nā anxiolytics kuʻuna) ua pale loa ia.

ʻO ka hoʻonui ʻana i ka hana cognitive i kēlā me kēia ʻano o ka hoʻomaha hopohopo ʻo ia ka mea e ʻoluʻolu ai ʻo Adamax i nā mea noiʻi a me nā mea maʻi..

COA

HPLC

MS

(1)Koina, N. V.; Sokolov, O. Y.; Gabaeva, M. V.; ʻO Grivennikov, I. A.; Andreeva, L. A.; Myasoedov, N. F.; Zozulya, A. A. Ke kāohi nei ʻo Semax a me Selank i nā Enkephalin-Degrading Enzymes o ke kanaka Serum. ʻO Russian Journal of Bioorganic Chemistry 2001, 27(3), 156-159. DOI: 10.1023/a:1011373002885.

(2)ʻO Vlasova, I. M.; Buravtcov, ʻO D. E.; Saletsky, A. M. Ka nānā ʻana o ka luminescence o nā ʻāpana koko i nā haʻawina o nā waiwai neuroprotective o ka lāʻau "Semax" i ka cerebral ischemia. Nūpepa o Applied Spectroscopy 2009, 76(1), 121-126. DOI: 10.1007/s10812-009-9141-y.

(3)Aberahama, M. H.; ʻEka, Ua ʻōlelo ʻo W. E.; Liu, X. ʻO nā mea wehewehe no adamantane a me kekahi o kāna mau mea. Nūpepa o nā wai Molekule 2021, 325. DOI: 10.1016/j.molliq.2020.114894.

(4)ʻo Dane, C.; Montgomery, A. P.; Kassiou, M. ʻO ka scaffold adamantane: Ma waho aʻe o kahi lipophilic moiety. ʻEpelika Nupepa o ka Lapaʻau Kemika 2025, 291. DOI: 10.1016/j.ejmech.2025.117592.

(5)ʻO Dmitrieva, V. ʻO G.; Povarova, O. V.; Skvortsova, V. I.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Hoʻopau ʻo Semax a me Pro-Gly-Pro i ka Transcription o Neurotrophins a me kā lākou Receptor Genes ma hope o Cerebral Ischemia. Cellular a me Molecular Neurobiology 2009, 30(1), 71-79. DOI: 10.1007/s10571-009-9432-0.

(6)ʻEremina, K. O.; Kudrin, V. S.; Saransari, P.; Huahana, S. S.; ʻO Grivennikov, I. A.; Myasoedov, N. F.; ʻO Rayevsky, K. S. Mai hoʻolohe, He ACTH(4-10) Analogue me Nootropic Properties, Hoʻoulu i nā ʻōnaehana lolo Dopaminergic a me Serotoninergic i nā Rodents. ʻImi ʻImi Neurochemical 2005, 30(12), 1493-1500. DOI: 10.1007/s11064-005-8826-8.

(7)ʻO Glazova, N. Y.; Manchenko, ʻO D. M.; Volodina, M. A.; Merchieva, S. A.; Andreeva, L. A.; Kudrin, V. S.; Myasoedov, N. F.; Levitskaya, N. ʻO G. Mai hoʻolohe, synthetic ACTH(4–10) analogue, Hoʻopau i nā loli a me nā neurochemical ma hope o ka hoʻolaha ʻana o ka fluvoxamine i ke ola mua i nā ʻiole keʻokeʻo. Nā neuropeptides 2021, 86. DOI: 10.1016/j.npep.2020.102114.

(8)Medvedeva, E. V.; ʻO Dmitrieva, V. ʻO G.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Mai hoʻolohe, he analog o ACTH(4−7), hoʻoponopono i ka hōʻike ʻana o nā genes pane pale i ka wā ʻeha lolo ischemic i nā ʻiole. Molecular Genetics a me Genomics 2017, 292(3), 635-653. DOI: 10.1007/s00438-017-1297-1.

(9)Pae, C.-U. Hiki i ka Therapeutic o "Semax" no ke kaumaha. CNS Spectrums 2014, 13(1), 20-21. DOI: 10.1017/s1092852900016102.

Kaʻina:

Ac-MEHFPGP-Adam-NH2

CAS:

N/A

M.W:

1033.21g/mol

Home Huli Whatsapp Nā lawelawe Huahana